2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 148.634 | 182.402 | 200.603 | 229.029 | 226.254 | 196.251 | 235.496 | 227.940 | 249.374 | 1.942.472 |
Total Income - EUR | 170.006 | 203.535 | 221.413 | 246.985 | 234.262 | 204.220 | 243.178 | 235.849 | 274.550 | 1.948.809 |
Total Expenses - EUR | 139.499 | 165.183 | 182.421 | 211.553 | 221.936 | 199.588 | 195.540 | 207.825 | 243.769 | 1.801.218 |
Gross Profit/Loss - EUR | 30.507 | 38.352 | 38.993 | 35.432 | 12.326 | 4.632 | 47.638 | 28.023 | 30.781 | 147.591 |
Net Profit/Loss - EUR | 24.798 | 31.774 | 36.517 | 33.239 | 10.064 | 2.810 | 45.536 | 25.787 | 28.421 | 90.447 |
Employees | 15 | 15 | 12 | 13 | 11 | 8 | 7 | 7 | 10 | 9 |
Check the financial reports for the company - Rivmed Srl
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 128.479 | 99.689 | 69.770 | 138.400 | 106.337 | 75.708 | 60.526 | 28.487 | 65.970 | 506.201 |
Current Assets | 69.934 | 61.243 | 40.001 | 29.624 | 37.037 | 35.789 | 54.473 | 62.451 | 43.408 | 133.049 |
Inventories | 0 | 0 | 0 | 204 | 0 | 350 | 0 | 0 | 0 | 0 |
Receivables | 58.402 | 46.129 | 14.837 | 18.721 | 11.818 | 3.623 | 15.132 | 33.729 | 40.412 | 19.758 |
Cash | 11.532 | 2.858 | 2.168 | 2.103 | 985 | 2.873 | 2.954 | 1.347 | 974 | 43.291 |
Shareholders Funds | 72.019 | 31.854 | 36.596 | 54.806 | 57.486 | 41.701 | 58.011 | 25.860 | 54.203 | 90.807 |
Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 300 |
Debts | 26.179 | 129.079 | 15.793 | 73.832 | 59.246 | 48.576 | 42.934 | 58.670 | 55.174 | 524.218 |
Income in Advance | 100.583 | 78.964 | 57.382 | 39.387 | 30.633 | 22.212 | 14.054 | 6.408 | 0 | 24.225 |
Exchange rate - RON | 1 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
Main CAEN | "8622 - 8622" | |||||||||
CAEN Financial Year |
8622
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Rivmed Srl